Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

RDS2 Solutions

RDS2 Solutions?uq=8lCq2teR
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
2 INVESTORS
Description

Owner and operator of a drug development company intended to facilitate research and development of vasoactive intestinal peptide drugs. The company's drug development services focus on combining vasoactive intestinal peptides that have the potential to provide superior efficacy for lung injury, inflammation, fibrosis, wound healing, method of delivery and disease indications, enabling medical researchers to develop drugs and cure idiopathic pulmonary fibrosis quickly and cost effectively, eliminating side-effects of commercial drugs.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 25 Health Sciences Drive
  • Suite 208-B
  • Stony Brook, NY 11794
  • United States

+1 (631) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore RDS2 Solutions’s full profile, request a free trial.

RDS2 Solutions Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2017 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

RDS2 Solutions Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Stony Brook Center Of Excellence Accelerator/Incubator Minority 000 0000 000000 0
Long Island High Technology Incubator Accelerator/Incubator 000 0000 000000 0

RDS2 Solutions Executive Team (1)

Name Title Board
Seat
Contact
Info
Anthony Szema MD Founder, President & Chief Executive Officer